AI-Powered Antibiotics Show Promise Against Drug-Resistant Bacteria
Leveraging advanced generative AI techniques, researchers have made promising strides in the design of novel antibiotics capable of combating drug-resistant bacteria like MRSA.
Leveraging advanced generative AI techniques, researchers have made promising strides in the design of novel antibiotics capable of combating drug-resistant bacteria like MRSA.
In a world where artificial intelligence increasingly drives innovation, Cloudian—a data storage company co-founded by an MIT alumnus—enables businesses to effectively manage the vast amounts of data AI models demand. Cloudian's solutions are designed to support the extensive data needs of machine learning systems while ensuring scalability and efficiency.
Leveraging machine-learning models, researchers have successfully developed polymers with enhanced resistance to tearing. This advancement represents a significant step forward in materials science, employing AI technology to identify stress-responsive molecules and create more resilient plastics.
Sweden's BoardClic has secured €1.65 million to enhance its AI-driven solutions, aiming to revolutionize boardroom processes and governance across Europe.
MIT scientists unveil VaxSeer, a cutting-edge AI tool that enhances the selection of flu vaccine strains by predicting virus evolution and antigenicity. This innovation aims to significantly improve the efficacy of vaccines and reduce dependence on traditional guessing methods.
Stay informed with curated insights delivered weekly to your inbox.